Thursday, May 29, 2025 | 06:00 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Cipla Ltd

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

08:27 AM, 11th Apr 2025

Company has received final approval from USFDA for ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound) 100 mg/vial Single-Dose Vial (Protein-bound Paclitaxel) on 10th April 2025

More Cipla Ltd Announcements